SO-15 Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Bruno Sangro, Stephen L. Chan, Robin Kate Kelley, George Lau, Masatoshi Kudo, Wattana Sukeepaisarnjaroen, Enrico de Toni, Junji Furuse, Yoon‐Koo Kang, Peter R. Galle, Lorenza Rimassa, Alexandra Heurgué, Vincent C. Tam, Thông Dao, Satheesh Chiradoni Thungappa, В. В. Бредер, Y. Ostapenko, María Reig, M. Makowsky, Charu Gupta, Alejandra Negro, Ghassan K. Abou‐Alfa